Manel Kraiem

Manel Kraiem

Company: Innate Pharma

Job title: ADC Scientific Leader, Project Manager, IPRL


Delving into the Newest ADC Technologies: Site-Specific Conjugation Based on Transglutaminase 12:00 pm

 Explore site-specific conjugation based on bacterial transglutaminase (BTG): platforms with high potential  Review site-specific conjugation of native vs silent antibodies: positive and negative aspects Focus on Innate-Pharma BTG technology  Read more

day: Track A - Day 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.